BR9711734A - Forma de dosagem de libera-Æo controlada de monochidrocloreto de ¬r-(z)¾-alfa-(metÄxiimino)-alfa-(1-azabiciclo¬2.2.2¾oct-3-il)acetonitrila - Google Patents
Forma de dosagem de libera-Æo controlada de monochidrocloreto de ¬r-(z)¾-alfa-(metÄxiimino)-alfa-(1-azabiciclo¬2.2.2¾oct-3-il)acetonitrilaInfo
- Publication number
- BR9711734A BR9711734A BR9711734A BR9711734A BR9711734A BR 9711734 A BR9711734 A BR 9711734A BR 9711734 A BR9711734 A BR 9711734A BR 9711734 A BR9711734 A BR 9711734A BR 9711734 A BR9711734 A BR 9711734A
- Authority
- BR
- Brazil
- Prior art keywords
- alpha
- monochlorochloride
- metäxiimino
- azabicyclo
- alfa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619074.9A GB9619074D0 (en) | 1996-09-12 | 1996-09-12 | Composition |
| PCT/GB1997/002418 WO1998010762A2 (en) | 1996-09-12 | 1997-09-08 | Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2oct-c-yl)acetonitrile monohydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9711734A true BR9711734A (pt) | 1999-08-24 |
Family
ID=10799833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9711734A BR9711734A (pt) | 1996-09-12 | 1997-09-08 | Forma de dosagem de libera-Æo controlada de monochidrocloreto de ¬r-(z)¾-alfa-(metÄxiimino)-alfa-(1-azabiciclo¬2.2.2¾oct-3-il)acetonitrila |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0929301A2 (de) |
| JP (1) | JP2001500150A (de) |
| KR (1) | KR20000036039A (de) |
| CN (2) | CN1235544A (de) |
| AR (1) | AR008176A1 (de) |
| AU (1) | AU724086B2 (de) |
| BR (1) | BR9711734A (de) |
| CA (1) | CA2265661A1 (de) |
| CO (1) | CO5031291A1 (de) |
| CZ (1) | CZ83299A3 (de) |
| GB (1) | GB9619074D0 (de) |
| HU (1) | HUP9904401A3 (de) |
| ID (1) | ID19589A (de) |
| IL (1) | IL128781A0 (de) |
| MA (1) | MA24359A1 (de) |
| NO (1) | NO991194D0 (de) |
| NZ (1) | NZ334268A (de) |
| PE (1) | PE2499A1 (de) |
| PL (1) | PL332074A1 (de) |
| TR (1) | TR199900505T2 (de) |
| WO (1) | WO1998010762A2 (de) |
| ZA (1) | ZA978133B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2775597B1 (fr) * | 1998-03-04 | 2001-04-20 | Gattefosse Ets Sa | Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication |
| US6451343B1 (en) | 1998-03-11 | 2002-09-17 | Smithkline Beecham Corporation | Composition for treating dementia and Alzheimer's disease |
| DE19918325A1 (de) * | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
| FR2796840B1 (fr) * | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | Comprimes faiblement doses et procede de preparation |
| US6733781B2 (en) * | 2000-12-06 | 2004-05-11 | Wyeth | Fast dissolving tablet |
| PE20040134A1 (es) | 2002-07-25 | 2004-03-06 | Pharmacia Corp | Forma de dosificacion de una vez al dia de pramipexol |
| EP1617838A4 (de) * | 2003-04-25 | 2011-07-06 | Mitsubishi Tanabe Pharma Corp | Zusammensetzung für die orale verabreichung mit alkylendioxybenzol-derivaten |
| PL1628642T3 (pl) * | 2003-05-14 | 2007-01-31 | Aptalis Pharma Ltd | Kontrolowane uwalnianie lekarstwa z kompozycji odpornej in vivo na mechaniczny stres |
| US20050142191A1 (en) * | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| JP2005272347A (ja) * | 2004-03-24 | 2005-10-06 | Ohara Yakuhin Kogyo Kk | 固形製剤の製造方法 |
| UA93608C2 (ru) | 2004-08-13 | 2011-02-25 | Берингер Ингельхайм Интернациональ Гмбх | композициЯ таблетки пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, СПОСОБ EE ИЗГОТОВЛЕНИЯ И EE ПРИМЕНЕНИЕ |
| WO2006015943A2 (en) * | 2004-08-13 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| EP1970056A1 (de) * | 2007-03-15 | 2008-09-17 | Polichem S.A. | Zeitspezifische Dosierformen mit verzögerter/pulsatiler Freisetzung |
| US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE269330T1 (de) * | 1989-04-13 | 2004-07-15 | Beecham Group Plc | Chemische verbindungen |
| GB9409718D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
| GB9421472D0 (en) * | 1994-10-25 | 1994-12-07 | Smithkline Beecham Plc | Novel methods |
| AR004178A1 (es) * | 1995-07-29 | 1998-11-04 | Smithkline Beecham Plc | Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. |
-
1996
- 1996-09-12 GB GBGB9619074.9A patent/GB9619074D0/en active Pending
-
1997
- 1997-09-08 HU HU9904401A patent/HUP9904401A3/hu unknown
- 1997-09-08 CA CA002265661A patent/CA2265661A1/en not_active Abandoned
- 1997-09-08 WO PCT/GB1997/002418 patent/WO1998010762A2/en not_active Application Discontinuation
- 1997-09-08 AU AU41288/97A patent/AU724086B2/en not_active Ceased
- 1997-09-08 PL PL97332074A patent/PL332074A1/xx unknown
- 1997-09-08 CN CN97199411A patent/CN1235544A/zh active Pending
- 1997-09-08 JP JP10513352A patent/JP2001500150A/ja active Pending
- 1997-09-08 NZ NZ334268A patent/NZ334268A/xx unknown
- 1997-09-08 KR KR1019997002030A patent/KR20000036039A/ko not_active Application Discontinuation
- 1997-09-08 IL IL12878197A patent/IL128781A0/xx unknown
- 1997-09-08 TR TR1999/00505T patent/TR199900505T2/xx unknown
- 1997-09-08 CZ CZ99832A patent/CZ83299A3/cs unknown
- 1997-09-08 EP EP97939064A patent/EP0929301A2/de not_active Withdrawn
- 1997-09-08 BR BR9711734A patent/BR9711734A/pt unknown
- 1997-09-09 CO CO97052280A patent/CO5031291A1/es unknown
- 1997-09-10 PE PE1997000805A patent/PE2499A1/es not_active Application Discontinuation
- 1997-09-10 AR ARP970104130A patent/AR008176A1/es not_active Application Discontinuation
- 1997-09-10 ZA ZA978133A patent/ZA978133B/xx unknown
- 1997-09-10 MA MA24792A patent/MA24359A1/fr unknown
- 1997-09-10 ID IDP973137A patent/ID19589A/id unknown
-
1999
- 1999-03-11 NO NO991194A patent/NO991194D0/no unknown
-
2003
- 2003-01-23 CN CN03102977A patent/CN1446535A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000036039A (ko) | 2000-06-26 |
| NO991194L (no) | 1999-03-11 |
| NO991194D0 (no) | 1999-03-11 |
| NZ334268A (en) | 2000-10-27 |
| AR008176A1 (es) | 1999-12-09 |
| GB9619074D0 (en) | 1996-10-23 |
| PL332074A1 (en) | 1999-08-30 |
| CN1235544A (zh) | 1999-11-17 |
| CN1446535A (zh) | 2003-10-08 |
| WO1998010762A2 (en) | 1998-03-19 |
| JP2001500150A (ja) | 2001-01-09 |
| CZ83299A3 (cs) | 1999-08-11 |
| HUP9904401A3 (en) | 2001-03-28 |
| CO5031291A1 (es) | 2001-04-27 |
| EP0929301A2 (de) | 1999-07-21 |
| HUP9904401A2 (hu) | 2000-06-28 |
| IL128781A0 (en) | 2000-01-31 |
| MA24359A1 (fr) | 1998-07-01 |
| AU724086B2 (en) | 2000-09-14 |
| PE2499A1 (es) | 1999-03-24 |
| CA2265661A1 (en) | 1998-03-19 |
| ID19589A (id) | 1998-07-23 |
| TR199900505T2 (de) | 1999-06-21 |
| WO1998010762A3 (en) | 1998-06-04 |
| ZA978133B (en) | 1999-04-12 |
| AU4128897A (en) | 1998-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9900540A (et) | Omeprasooli ravimvorm | |
| IS5722A (is) | Pýróló [2,3-dl]pírimídín efnasambönd | |
| DE69816852D1 (de) | Zyklonabscheider | |
| EE04293B1 (et) | Stabiilsed lüofiliseeritud ravimvormid | |
| ZA987551B (en) | Solid pharmaceutical dosage forms | |
| IS5344A (is) | 2-Amínópýridín sem innihalda sambrædda hringtengihópa sem NOS latar | |
| DK0839039T3 (da) | Paroxetinpræparater med styret frigivelse | |
| DK0891978T3 (da) | 5H-Thiazol(3,2-a)pyrimidinderivativer | |
| BR9711734A (pt) | Forma de dosagem de libera-Æo controlada de monochidrocloreto de ¬r-(z)¾-alfa-(metÄxiimino)-alfa-(1-azabiciclo¬2.2.2¾oct-3-il)acetonitrila | |
| ATE321784T1 (de) | Pthrp analogen | |
| IS4848A (is) | Lyfjafræðilega gagnleg efnasambönd | |
| GB9823102D0 (en) | Pharmaceutically active compounds | |
| ZA977807B (en) | New pharmaceutically active compounds. | |
| PL340372A1 (en) | Novel 3,6x-hemiketals of 9a-azalydes class | |
| DE59804098D1 (de) | Verdampferanordnung | |
| PT964867E (pt) | Antagonistas da taquicinima | |
| GB2321065B (en) | Rotary braider | |
| PL338781A1 (en) | Dosage form | |
| NO995033D0 (no) | 6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser | |
| EE04318B1 (et) | Parendatud toimega LHRH antagonistid | |
| IL131617A0 (en) | 5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds | |
| FR2762641B1 (fr) | Serrure de meuble | |
| ID23006A (id) | 13-dihidro-3' aziridino antrasiklina | |
| SE9704874D0 (sv) | New pharmaceutically active compounds | |
| SE9700660D0 (sv) | Pharmaceutically active compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |